CSC
DARE icon

Caldwell Sutter Capital’s Dare Bioscience DARE Stock Holding History

Caldwell Sutter Capital’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$211 Buy
100
+83
+488% +$186 ﹤0.01% 905
2026
Q1 		$31 Hold
17
– – ﹤0.01% 876
2025
Q4 		$33 Hold
17
– – ﹤0.01% 863
2025
Q3 		$36 Hold
17
– – ﹤0.01% 856
2025
Q2 		$41 Hold
17
– – ﹤0.01% 839
2025
Q1 		$49 Hold
17
– – ﹤0.01% 873
2024
Q4 		$53 Hold
17
– – ﹤0.01% 880
2024
Q3 		$55 Hold
17
– – ﹤0.01% 890
2024
Q2 		$67 Hold
17
– – ﹤0.01% 901
2024
Q1 		$98 Hold
17
– – ﹤0.01% 896
2023
Q4 		$62 Hold
17
– – ﹤0.01% 937
2023
Q3 		$92 Hold
17
– – ﹤0.01% 866
2023
Q2 		$182 Buy
+17
New +$202 ﹤0.01% 843

Other funds holding DARE

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Caldwell Sutter Capital's DARE Position: Q2 2026 in Review

Caldwell Sutter Capital increased its Dare Bioscience (DARE) stake by 488% in Q2 2026, buying an estimated $186 and bringing the position to 100 shares worth $211. The position accounts for ﹤0.01% of the portfolio, ranked #905.

Caldwell Sutter Capital first reported a position in DARE in Q2 2023 and has held it in 13 quarters since. 27 funds tracked by Wall St. Rank hold DARE as of Q2 2026.

  • Caldwell Sutter Capital held 100 shares of Dare Bioscience worth $211 as of Q2 2026.
  • Caldwell Sutter Capital bought 83 Dare Bioscience shares in Q2 2026, an estimated $186.
  • Dare Bioscience made up ﹤0.01% of Caldwell Sutter Capital's portfolio in Q2 2026, its #905 holding.
  • Caldwell Sutter Capital first reported a position in Dare Bioscience in Q2 2023 and has held it in 13 quarters since.
  • 27 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2026.

Based on Caldwell Sutter Capital's 13F filing for Q2 2026, filed 5 Aug 2026.